Muscle Contusion Market Size, Share, Industry, Forecast and outlook (2024-2031)

Muscle Contusion Market is segmented By Drug Type (Nonnarcotic Analgesics, Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Narcotic Analgesics), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030.

Muscle Contusion Market Overview

Muscle Contusion Market is estimated to reach at a CAGR of 6.04 % during the forecast period (2023-2030).

Contusions develop when a blunt instrument strikes a region of the body directly or repeatedly, crushing underlying muscle fibers and connective tissue without breaking the skin. Falling or slamming the body against a hard surface can cause a contusion. A bone contusion (bruise) or even a fracture may occur due to the muscle contusion (broken bone). Contusions get better quickly with simple treatment measures such as pain relief medications.

Muscle Contusion Market Scope

To Get a Free Sample Click here

Muscle Contusion Market Dynamics

Increasing product launches by the key players are expected to drive market growth.

The U.S. Food and Drug Administration (FDA) approved Zynrelef (extended-release dual-acting local anesthetic of bupivacaine and meloxicam) for pain treatment in May 2021, according to Heron Therapeutics, Inc. Moreover, The United States Food and Drug Administration granted Strides Pharma Science Limited approval for Ibuprofen Oral Suspension in February 2021. (USFDA). Therefore, the market is expected to drive in the forecast period.

Restraint:

Medications are a mainstay of treatment in the injured athletes for their pain relief and healing properties. As these drugs have potential healing benefits, it also has common side effects. For instance, Narcotic Analgesics, Drowsiness and impaired judgment often occur with these medicines, constipation, nausea, or vomiting. Moreover, withdrawal symptoms are common when a patient stops taking a narcotic. Symptoms include a strong desire for the medicine (craving), yawning, insomnia, restlessness, mood swings, or diarrhea. Therefore, above are some of the factors the market is expected to get hampered in the forecast period.

COVID-19 Impact Analysis

The current COVID-19 pandemic led elite athletes from various sports to cancel events and training sessions, which lasted eight weeks in several countries (Italy, Spain, and others). Long-term detraining, such as the COVID-19 forced stop, is well documented to result in a significant decrease in maximal oxygen consumption (VO2max), the loss of previously gained increases in endurance capacity, and, most critically, a loss of muscular strength and mass. The muscular-tendon issue casts serious doubt on a quick return to professional competition. Athletes lose muscular mass, strength, and power after eight weeks of detraining due to decreasing electromyographic activity (EMG), which reduces muscle activation. In both non-contact and contact sports like soccer, such a decrease in skeletal muscle activity could significantly increase the risk of injury. Moreover, the consistent virus spread has significantly obstructed the supply chain of the muscle contusion market. Thus, the market will undergo impetus during the forecast period.

Muscle Contusion Market Segment Analysis

Nonsteroidal Anti-inflammatory Drugs (NSAIDs) segment is expected to hold the largest market share in muscle contusion market.

The nonsteroidal anti-inflammatory drugs segment accounted for the largest market share in 2020. Muscle injuries are a broad term that encompasses a variety of diseases, and they are common among top and amateur athletes and the general public. Skeletal muscle injuries account for a significant part of all sports medicine injuries, accounting for 10% to 55% of all sustained injuries. The muscles and muscle groups most commonly involved are the hamstrings, rectus femoris, and medial head of the gastrocnemius. For muscular injury, most doctors prefer nonsteroidal anti-inflammatory medications (NSAIDs). Nonsteroidal anti-inflammatory medications (NSAIDs) are a type of medication that relieves pain, lowers fever, avoids blood clots, and reduces inflammation in larger doses. Non-selective NSAIDs and COX-2 selective NSAIDs are also available. The majority of NSAIDs are non-selective, inhibiting both COX-1 and COX-2 activity. Aspirin, ibuprofen, and naproxen are the most common NSAIDs, all of which are accessible over-the-counter (OTC) in most countries. For instance, ibuprofen, known under brand names such as Advil and Motrin, is one of several drugs in a family called nonsteroidal anti-inflammatory drugs (NSAIDs), most commonly used to treat mild to moderate muscle pain. Therefore, muscle injury has increased the demand for nonsteroidal anti-inflammatory drugs (NSAIDs). Thus, the market segment is expected to hold the largest market share in the forecast period.

Muscle Contusion Market Geographical Share

North America region holds the largest market share in the global muscle contusion market

In 2020, North America accounted for the highest revenue share. Increasing prevalence of sports injuries, rising cases of trauma, product launches by the key players, well-established healthcare facilities in the region are a few factors that the market is expected to boost in the forecast period. For instance, injuries can occur in any sport, whether from the trauma of contact with other players or from overuse or misuse of a body part. According to the National Safety Council (NSC), in 2020, bicycling accounted for about 426,000 injuries, most of any sports and recreation category. With or without equipment, exercise followed with about 378,000 injuries, while ATV, moped and minibike use with 230,000 injuries, and skateboard, scooter and hoverboard use, with 218,00 injuries, ranked third and fourth.

Moreover, the concern is growing about the risks of sports-related concussions such as football can be expected to result in a higher number of injuries than a noncontact sport such as swimming. The problem also affects thousands of young people who engage in various sports. According to the NSC, being struck by another person or object is the leading cause of unintentional injury for teens and young adults ages 15 to 24. Therefore, from the above statements, the North American region is expected to hold the largest market share in the forecast period.

Muscle Contusion Market Companies

Major key players in the muscle contusion market are Johnson & Johnson Consumer Inc., Pfizer Inc., GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Bayer AG, Taro Pharmaceuticals U.S.A., Inc., Sanofi, Horizon Therapeutics plc, AstraZeneca and Assertio Holdings, Inc.

Johnson &Johnson Inc:

Overview:

Johnson &Johnson is an American multinational corporation. The company is into medical devices, pharmaceuticals, and consumer packaged goods. Johnson & Johnson's brands include more household names of medications and first aid supplies. Its well-known consumer products are the Band-Aid Brand line of bandages, Tylenol medications, Johnsons Baby products, Neutrogena skin and beauty products, Clean &Clear facial wash, and Acuvue contact lenses. Johnson & Johnson's pharmaceutical arm is Janssen Pharmaceutical.

Product Portfolio:

Tylenol: Pain accompanying minor acute soft-tissue injuries may be relieved by a short course of nonnarcotic analgesics with acetaminophen (Tylenol)